Health Canada — Medical Devices · Canada · 2022-12-02 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: BD has confirmed through complaint investigation that a single lot of BBL™ Chocolate II Agar has misformulated nicotinamide adenine dinucleotide (NAD) concentration in a portion of the batch. Specifically affected are box numbers 0002 through 0097. These boxes correlate to timestamps on the plates of 11:34 through 13:51. All other box numbers and plate stamps are unaffected and perform as intended. Recall start date: November 21, 2022
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.